According to Jiangsu Hengrui Medicine
's latest financial reports the company has $2.45 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $2.59 B | -11.8% |
2021-12-31 | $2.93 B | 16.61% |
2020-12-31 | $2.51 B | 29.76% |
2019-12-31 | $1.94 B | 19.66% |
2018-12-31 | $1.62 B | 147.39% |
2017-12-31 | $0.65 B | -7.28% |
2016-12-31 | $0.70 B | -10.68% |
2015-12-31 | $0.79 B | 42.19% |
2014-12-31 | $0.55 B | 55.4% |
2013-12-31 | $0.35 B | 68.09% |
2012-12-31 | $0.21 B | 41.16% |
2011-12-31 | $0.15 B | 0.38% |
2010-12-31 | $0.15 B | 45.33% |
2009-12-31 | $0.10 B | 51.64% |
2008-12-31 | $68.28 M | -40.97% |
2007-12-31 | $0.11 B | 56.61% |
2006-12-31 | $73.85 M | 38.12% |
2005-12-31 | $53.47 M | 21.61% |
2004-12-31 | $43.96 M | 80.77% |
2003-12-31 | $24.32 M | 5.2% |
2002-12-31 | $23.12 M | -29.38% |
2001-12-31 | $32.73 M |